Table 1.
Coronary Artery Tissue Samples
| Sample | Age, y | Race and Sex | LAD Blockage | Past Medical History |
|---|---|---|---|---|
| CAD 1 | 48 | White, M | 40% | Cirrhosis |
| CAD 2 | 53 | White, M | 50% | N/A |
| CAD 3 | 53 | White, M | 90% | Stroke |
| CAD 4 | 47 | White, M | >95% | Drug overdose |
| CAD 5 | 50 | White, M | 100% | Ischemic myopathy |
| CAD 6 | 55 | White, M | 100% | Stroke |
| Control 1 | 48 | White, M | 0% | N/A |
| Control 2 | 53 | White, M | 0% | N/A |
| Control 3 | 53 | White, M | 0% | N/A |
| Control 4 | 47 | White, M | 0% | N/A |
| Control 5 | 50 | White, M | 0% | N/A |
| Control 6 | 55 | White, M | 0% | N/A |
Note that each coronary artery disease sample is matched by a non‐coronary artery disease control sample (eg, coronary artery disease 1 vs Control 1; coronary artery disease 2 vs Control 2; etc). CAD indicates coronary artery disease.